COc1ccc(-c2ccc3c(c2)[C@@H]2C[C@H](N(C)S(=O)(=O)c4ccccc4)[C@H]([C@H](C)O)C(=O)N2CC3)cc1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?